Electroceuticals: Technologies and Global Markets
Market Research Report I 2022-06-30 I 117 Pages I BCC Research
Description
Report Scope:
This report highlights the current and future market potential for electroceuticals. It provides a detailed analysis of the competitive environment, regulatory scenario, and the drivers, restraints, opportunities, and trends in the market. The report also offers market projections through 2027.
This report covers the overall electroceuticals market, including cardiac pacemakers, implantable cardiac defibrillators, hearing aids and implants, and neurostimulation devices. The report also analyzes various end users of electroceuticals.
For this report, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW), which includes Latin America, the Middle East and Africa). Major countries, including the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are analyzed. Market data was provided for 2020, which served as the base year, and forecasts are estimated through 2027. Estimated values are based on product manufacturers' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
- 19 data tables and 24 additional tables
- An overview of global markets and technologies for electroceuticals
- Analyses of global market trends, with data from 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Discussion on how electroceuticals are used as an alternative to drug-based remedies and analyses of endogenous and exogenous factors that are impacting the global market growth
- Coverage of several diseases such as epilepsy, cardiovascular diseases, rheumatoid arthritis and diabetes and their treatment using electroceuticals
- Information on RecoveryRx medical device, which is used for the treatment of postoperative pain of opioid/NSAID therapy
- Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size, and forecast
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Company profiles of major players Abbott Laboratories, Boston Scientific, GlaxoSmithKline plc, Medtronic plc, Edwards Lifesciences Corp.
Executive Summary
Summary:
The global electroceuticals market was valued at $REDACTED in 2020 and is expected to be valued at $REDACTED by the end of 2027, at a CAGR of REDACTED%. The market's growth is mainly attributed to the increasing incidence of neurological disorders and cardiac diseases.
Electroceuticals are medical devices that are used to restore health in patients. Patients can hold these devices against the skin, or they can be implanted. These devices, also known as bioelectric medicine, represent an alternative to drug-based remedies. They are usually not the first line of treatment, and tend to be used only when health cannot be restored with drugs. Most electroceuticals do not cure conditions, but can reduce pain and avoid affected parts of the body. Electroceuticals function through neurostimulation and modulation of the nervous system through electrical impulses. Electroceutical devices are used to treat several ailments and disorders related to neurology and cardiology through invasive and non-invasive methods.
The human nervous system works as the commander of the human body, and, as such, plays a major role in treating disorders of the body. Neurostimulation technology involves the alteration or modulation of nerves. Neurostimulation devices directly deliver electrical current or magnetic impulses to nerves to modify their activities.
Over the last 30 years, neurostimulation has emerged as one of the most dynamic and exciting therapy fields, and has been investigated for the treatment of a range of clinical conditions, including chronic pain, movement disorders (Parkinson's disease, tremor, dystonia and others), epilepsy (which affects 50 million people worldwide), functional restoration, and psychiatric, cardiovascular, gastrointestinal and genitourinary disorders. The potential of neurostimulation technology is being explored in several other clinical conditions, including obesity, tinnitus and central nervous system disorders.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing this Study
What's New in this Update?
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Executive Summary
Chapter 3 Overview
Introduction
Neurostimulation
Cardioverter Defibrillators and Cardiac Pacemakers
Public Access Defibrillators
Battery Technology for Implantable Cardiac Defibrillators
Regulatory Framework
United States
European Union
Japan
Chapter 4 Market Dynamics
Market Drivers
Increasing Incidence of CVD, Neurology and ENT Disorders
Aging Population
Increasing Healthcare Expenditures
Focus on Non-drug Therapies and Reducing Opioid Usage
Technology Innovations and New Product Developments
Market Restraints and Challenges
High Cost of Neurostimulation Procedures/Devices and Lack of Trained Healthcare Professionals
Inconsistent Reimbursement Policies
Chapter 5 Impact of COVID-19 Pandemic
Introduction
Impact on Neurostimulation Market
Impact on Market for ENT Devices
Chapter 6 Global Market for Electroceuticals by Product
Cardioverter Defibrillators and Cardiac Pacemakers
Neurostimulation
Spinal Cord Stimulation
Deep Brain Stimulation
Vagus Nerve Stimulation
Sacral Nerve Stimulation
Transcutaneous Electrical Nerve Stimulation
Other Stimulators
Hearing Aids and Implants
Hearing Aid Devices
Behind the Ear
Completely in the Canal
In the Ear
Hearing Implants
Cochlear Implants
Bone Anchored Hearing Implants
Middle Ear Implants
Chapter 7 Global Market for Electroceuticals by End User
Hospitals and Clinics
Homecare and Others
Chapter 8 Global Market for Electroceuticals by Region
North America
U.S.
Europe
Asia-Pacific
Japan
China
India
Rest of the World
Chapter 9 Patent Review
Introduction
Patents on Hearing Aids and Implants
Neurostimulation
Cardiac
Chapter 10 Competitive Landscape
Leading Companies in the Market for Neurostimulation Products
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Market for Hearing Aids and Implants by Company
Key Developments
Chapter 11 Company Profiles
ABBOTT LABORATORIES
AXONICS MODULATION TECHNOLOGIES INC.
BIOVENTUS LLC
BIOTRONIK SE & CO. KG
BOSTON SCIENTIFIC CORP.
COCHLEAR AMERICAS
COOK MEDICAL
EDWARDS LIFESCIENCES CORP.
GLAXOSMITHKLINE PLC
LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
LIVANOVA PLC
MEDICO S.P.A.
MEDTRONIC PLC
MICROPORT SCIENTIFIC CORP.
STRYKER CORP.
ZOLL MEDICAL CORP.
Chapter 12 Appendix: Acronyms
List of Tables
Summary Table A : Global Market for Electroceuticals, by Product, Through 2027
Table 1 : Regulatory Approval: U.S. vs. Europe
Table 2 : U.S. FDA Product Classification: Defibrillators
Table 3 : U.S. FDA Pacemaker Product Classification
Table 4 : U.S. FDA Neurostimulator Product Classification, 2019
Table 5 : U.S. FDA Cochlear Implant Product Classification
Table 6 : Global Incidence of All Stroke Types, 2019
Table 7 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
Table 8 : Number of Disability-adjusted Life Years (DALYs)for Neurological Disorders and Share of Global DALYs Projected for 2005 and 2030
Table 9 : Deaths Attributable to Neurological Disorders, 2005 and 2030
Table 10 : World Population, Age 60 and Older, 2000-2050
Table 11 : Global Market for Electroceuticals, by Product, 2020-2027
Table 12 : Global Market for Cardioverter Defibrillators and Cardiac Pacemakers, by Region, Through 2027
Table 13 : Global Market for Spinal Cord Stimulators, by Region, Through 2027
Table 14 : Global Market for Deep Brain Stimulators, by Region, Through 2027
Table 15 : Global Market for Vagus Nerve Stimulators, by Region, Through 2027
Table 16 : Global Market for Other Stimulators, by Region, Through 2027
Table 17 : Global Market for Hearing Aids and Implants, by Region, Through 2027
Table 18 : Global Market for Electroceuticals, by End User, 2020-2027
Table 19 : Global Market for Hospitals and Clinics, by Region, Through 2027
Table 20 : Hospitals with Notable Services
Table 21 : Global Market for Homecare and Others, by Region, Through 2027
Table 22 : Global Market for Electroceuticals, by Region, 2020-2027
Table 23 : North American Market for Electroceuticals, by Country, Through 2027
Table 24 : Funding by Federal Government for Treatment of Chronic Diseases
Table 25 : European Market for Electroceuticals, by Country, Through 2027
Table 26 : Asia-Pacific Market for Electroceuticals, by Country, Through 2027
Table 27 : China's Medical Device Regulations
Table 28 : Out-of-Pocket Health Expenditures in Argentina, 2015-2019
Table 29 : Analysis of Patents Related to Electroceuticals
Table 30 : Number of Patents Related to Neurostimulation, by Patent Holder, January 2020 to May 2022
Table 31 : Number of Patents Related to Cardiac Stimulation, by Patent Holder, January 2020 to May 2022
Table 32 : Global Market Shares of Spinal Cord Stimulation Devices, by Company, 2020
Table 33 : Global Market Shares of Deep Brain Stimulation Devices, by Company, 2020
Table 34 : Abbott: Product Portfolio
Table 35 : Bioness: Product Information
Table 36 : Product Portfolio
Table 37 : Medico S.p.A.: Main Products
Table 38 : Medico S.p.A.: Recent Developments
Table 39 : Medtronic: Product Portfolio
Table 40 : MicroPort Scientific Corp.: Product Portfolio
Table 41 : Zoll Medical Corp.: Product Portfolio
Table 42 : Acronyms Used in This Report
List of Figures
Summary Figure A : Global Market for Electroceuticals, 2020-2027
Figure 1 : Global Deaths from CVD, 2015 and 2030
Figure 2 : Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
Figure 3 : Global Market for Electroceuticals, by Product, 2020-2027
Figure 4 : Pacemakers
Figure 5 : Global Market for Electroceuticals, by End User, 2020-2027
Figure 6 : Number of Hospitals in the U.S., by Type, 2020
Figure 7 : Healthcare Expenditures in the U.S., 2015 and 2025
Figure 8 : Trends in Healthcare Spending, by Institution, 2015-2040
Figure 9 : North American Market Shares of Electroceuticals, by Country, 2021
Figure 10 : European Market Shares of Electroceuticals, by Country, 2021
Figure 11 : Asia-Pacific Market Shares of Electroceuticals, by Country, 2021
Figure 12 : Out-of-Pocket Health Expenditures in Argentina, 2015-2019
Figure 13 : Percentage of Patents on Hearing Aids and Implants, by Country, January 2020 to May 2022
Figure 14 : Percentage of Patents on Hearing Aids and Implants, by Patent Holder, January 2020 to May 2022
Figure 15 : Percentage of Patents Related to Neurostimulation, by Country, January 2020 to May 2022
Figure 16 : Global Market Shares of Spinal Cord Stimulation Devices, by Company, 2020
Figure 17 : Global Market Shares of Deep Brain Stimulation Devices, by Company, 2020
Figure 18 : Global Market Shares of Hearing Aids and Implants, by Company, 2020
Figure 19 : Global Market Shares of Hearing Aids and Implants, by Company, 2020
Figure 20 : Abbott: Annual Revenue, 2018-2021
Figure 21 : Abbott: Vascular Business Annual Revenue, 2018-2021
Figure 22 : Abbott: Revenue Share, by Country, 2021
Figure 23 : Boston Scientific: Annual Revenue, 2018-2021
Figure 24 : Boston Scientific: Revenue Share, by Business, 2021
Figure 25 : Boston Scientific: Revenue Share, by Region, 2021
Figure 26 : GlaxoSmithKline plc: Annual Revenue, 2018-2020
Figure 27 : GlaxoSmithKline plc: Revenue Share, by Business Segment, 2020
Figure 28 : Medtronic: Annual Revenue, 2018-2021
Figure 29 : Medtronic Coronary & Peripheral Vascular Segment: Annual Revenue, 2019-2021
Figure 30 : Medtronic: Revenue Share, by Region, 2021
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.